Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer

Objectives: The authors performed a systematic review and meta-analysis of randomized and nonrandomized trials on the efficacy of dexrazoxane in patients with breast cancer who were treated with anthracyclines with or without trastuzumab. Background: Breast cancer treatment with anthracyclines and t...

Full description

Bibliographic Details
Main Authors: Ariane V.S. Macedo, MD, MSc, Ludhmila A. Hajjar, MD, PhD, Alexander R. Lyon, MD, Bruno R. Nascimento, MD, PhD, Alessandro Putzu, MD, Lorenzo Rossi, MD, Rafael B. Costa, MD, Giovanni Landoni, MD, Angélica Nogueira-Rodrigues, MD, PhD, Antonio L.P. Ribeiro, MD, PhD
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:JACC. CardioOncology
Subjects:
cardiomyopathy
cardioprotection
cardiotoxicity
dexrazoxane
doxorubicin
heart failure
Online Access:http://www.sciencedirect.com/science/article/pii/S2666087319300146

Internet

http://www.sciencedirect.com/science/article/pii/S2666087319300146

Similar Items